2,291 results on '"Kreipe, Hans"'
Search Results
2. Diagnostic utility of ESR1 mutation detection in liquid biopsy of metastatic breast cancer patients
3. Knochenmarkhistologie bei Zytopenien: Beitrag zur hämatologischen Differenzialdiagnostik
4. Detection of a rare JAK2exon13InDel-mutation in chronic eosinophilic leukemia with bilateral cerebral infarctions and Löffler endocarditis
5. Immunohistochemical marker profiles for the differentiation of collagenous spherulosis from adenoid cystic carcinoma of the breast
6. Cytogenetics and genomics in CML and other myeloproliferative neoplasms
7. Inflammation and vascular remodeling in COVID-19 hearts
8. Prädiktive Pathologie für die Immuntherapie
9. Primäre Myelofibrose: Diagnostik, Klinik und Therapieoptionen
10. ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer
11. Zweitmeinungs- und Referenzpathologie beim Mammakarzinom
12. Zweitmeinungs- und Referenzpathologie
13. Nachruf auf Wolfgang Remmele: 16.05.1930–16.10.2021
14. Multimodal artificial intelligence models from baseline histopathology to predict prognosis in HR+ HER2- early breast cancer: Subgroup analysis.
15. Neoadjuvant dynamic marker-adjusted personalized therapy comparing trastuzumab-deruxtecan versus pacli-/docetaxel + carboplatin + trastuzumab + pertuzumab in HER2+ early breast cancer: WSG-ADAPT-HER2-IV.
16. Multiomic factor analysis for pathologic complete response (pCR) after 12 weeks of pembrolizumab + trastuzumab + pertuzumab in HER2-enriched (HER2-E) early breast cancer (eBC) in the Keyriched-1 trial.
17. Medikamentös induzierte Knochenmarkveränderungen
18. The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer—a pooled analysis of the randomised clinical trials PlanB and SUCCESS C
19. Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study
20. Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial
21. De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR–): survival outcomes from a multicentre, open-label, randomised, phase 2 trial
22. Lymphoproliferative Erkrankungen des weiblichen und männlichen Genitaltrakts sowie der Mamma
23. Lymphatische Neoplasien und ihre Manifestation im Knochenmark
24. Neoplastische Bildungsstörungen der Hämatopoiese mit Ausreifungsverlust
25. Veränderungen des gesamten Knochenmarks und Stromas
26. Neoplastische Bildungsstörungen der Hämatopoiese mit erhaltener Ausreifung
27. Reaktive unilineäre Zytopenien und Zytosen
28. Histiozytäre Neoplasien
29. Untersuchungsmethoden des Knochenmarks und Physiologie der Blutbildung
30. AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024
31. Chronic Myeloid Leukemia, Polycythemia Vera Progression
32. Chronic Myeloid Leukemia, BCR-ABL1 Positive
33. Polycythemia Vera
34. CD20/CD79a/PAX5/CD3-negative post-transplant lymphoma with aberrant actin and desmin co-expression—a potential differential diagnostic pitfall between PTLD and PTSMT
35. Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing
36. Prädiktive Mutationsdiagnostik bei Mammakarzinomen
37. A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy
38. Microenvironment-induced restoration of cohesive growth associated with focal activation of P-cadherin expression in lobular breast carcinoma metastatic to the colon
39. Metastasen
40. E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements
41. Molecular Profiling of Vascular Remodeling in Chronic Pulmonary Disease
42. Identification of Patients with Early HR+ HER2− Breast Cancer at High Risk of Recurrence
43. Malignant phyllodes tumor and invasive lobular breast carcinoma: Morpho-molecular characterization of an uncommon collision tumor and review of the literature
44. Microenvironment‐induced restoration of cohesive growth associated with focal activation of P‐cadherin expression in lobular breast carcinoma metastatic to the colon
45. Bicentric Retrospective Analysis of en Bloc Resection and Muscularis Mucosae Detection Rate in Non-Muscle Invasive Bladder Tumors: A Real-World Scenario
46. Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)—a translational analysis of the prospective WSG PlanB trial
47. Genome-wide DNA methylation profiling is able to identify prefibrotic PMF cases at risk for progression to myelofibrosis
48. Qualitätssicherung in der diagnostischen In-situ-Hybridisierung – Erfahrungen der QuIP
49. A 19-year-old patient with atypical chronic myeloid leukemia
50. Mutations associated with age-related clonal hematopoiesis in PMF patients with rapid progression to myelofibrosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.